Learn more about how TLC’s BPM research project is working to identify genetics that help unravel the BFRB code with Dr. Jeremiah Scharf and Dr. John Piacentini.
This webinar will be recorded and posted to TLC's YouTube. *Please be on time as webinar entrance closes after 10 minutes.*
Dr. Jeremiah Scharf is a behavioral neurologist and tic disorder specialist as well as a clinical researcher in molecular genetics. He specializes clinically in disorders that lie at the interface between neurology and psychiatry, particularly Tourette Syndrome (TS) and related conditions. His research efforts focus on the genetic underpinnings of TS as well as exploration of heritable subphenotypes of this disorder that might prove useful for future research studies and clinical trials.
Dr. Scharf completed his BS in Molecular Biophysics and Biochemistry from Yale University, his MD from the Harvard-MIT Division of Health Sciences and Technology at Harvard Medical School, and his Ph.D. in Neurobiology from Harvard University, where he studied neurogenetics under Dr. Louis Kunkel. Following his neurology residency at Massachusetts General and Brigham and Women's Hospitals, Dr. Scharf completed subspecialty training in behavioral neurology and neuropsychiatry at the Brigham Behavioral Neurology Group as well as a research fellowship in the PNGU under Dr. David Pauls.
Dr. Scharf is a member of the Steering Committee for the TSA International Consortium for Genetics (TSAICG), a team of clinicians and molecular geneticists dedicated to identifying susceptibility genes for TS. He has received research grants from the Tourette Syndrome Association, American Academy of Neurology Foundation, and the National Institutes for Mental Health (NIMH).
Dr. John Piacentini is Professor of Psychiatry and Biobehavioral Sciences and Chief of Child Psychology (in Medical Psychology) in the David Geffen School of Medicine at UCLA and the UCLA Semel Institute where he directs the Child OCD, Anxiety and Tic Disorders Program, the Center for Child Anxiety, Resilience, Education and Support (CARES), and Tourette Association of America Center of Excellence. He received his PhD in Clinical Psychology from the University of Georgia and completed post-doctoral training and was a faculty member at the New York State Psychiatric Institute, Columbia University. A board-certified clinical child and adolescent psychologist, his work focuses on the development and dissemination of science-based individual- and family-based treatments for youth with BFRBs, OCD, tic, and anxiety disorders. Through the UCLA CARES Center, Dr. Piacentini and his team have developed a number of community-based programs aimed at preventing childhood anxiety disorders. He has authored over 300 scientific publications, including seven books, and his research has been funded by the National Institute of Mental Health, International OCD Foundation, Tourette Association of America, TLC Foundation for BFRBs, and other leading foundations and philanthropic organizations. Dr. Piacentini is also a past-president of the American Board of Professional Psychology (ABPP) and the Society for Clinical Child and Adolescent Psychology, and a founding fellow of the Academy of Cognitive Therapy. He is a frequent lecturer and with his team, has trained hundreds of mental health clinicians in cognitive-behavior therapy and other evidence-based treatments and provided care to over 1000 children, adolescents, and their families.Dr. Piacentini currently serves as TLC’s Board and SAB President.
Thursday, October 6th, Noon to 1 pm PST
Dr. Jeremiah Scharf and Dr. John Piacentini